Tag: therapeutics,
Cadrenal Therapeutics downsizes IPO, looks to raise $7 million
There has been an increase in the number of pharma companies taking the IPO route to enhance their research and development activities — the trend is continuing in 2023. There […]
The post Cadrenal Therapeutics downsizes IPO, looks to raise $7 million first appeared on AlphaStreet.
Magenta Therapeutics soars 37% on data for acute myeloid leukemia candidate
Amgen agrees to acquire Horizon Therapeutics in $27.8bn deal
The acquisition will add several approved drugs into Amgen’s portfolio, along with potential new medicines from Horizon’s R&D pipeline.
Read more: Amgen agrees to acquire Horizon Therapeutics in $27.8bn deal
Carrick Therapeutics raises $60m for novel cancer treatments
The Dublin start-up raised $25m in a Series C round and secured $35m from Pfizer to develop an advanced breast cancer treatment.
Read more: Carrick Therapeutics raises $60m for novel cancer treatments
Re-Vana Therapeutics raises $11.9m to boost eye disease treatment
A spin-out of Queen’s University Belfast, Re-Vana is working to improve the treatment of eye diseases by reducing the need for frequent drug administrations.
Read more: Re-Vana Therapeutics raises $11.9m to boost eye disease treatment
ALS drug developer Coya Therapeutics files for proposed $17M IPO
Malaysian biotech CytoMed Therapeutics files for $10M US IPO
Sage Therapeutics Inc (SAGE) Q3 2022 Earnings Call Transcript
Sage Therapeutics Inc (NASDAQ:SAGE) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Helen Rubinstein — Director of Investor Relations Barry Greene — Chief Executive Officer Jeff Jonas — Chief Innovation Officer Chris Benecchi — Chief Business […]
The post Sage Therapeutics Inc (SAGE) Q3 2022 Earnings Call Transcript first appeared on AlphaStreet.
Cara Therapeutics Inc (CARA) Q3 2022 Earnings Call Transcript
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Matthew Murphy — Investor Relations Manager Christopher Posner — Chief Executive Officer, President, and Director Ryan Maynard — Chief Financial Officer Joana […]
The post Cara Therapeutics Inc (CARA) Q3 2022 Earnings Call Transcript first appeared on AlphaStreet.